- Home
- SISI vs HSCS Comparison
SISI vs HSCS Comparison
Compare SISI & HSCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SISI
- HSCS
- Stock Information
- Founded
- SISI 1997
- HSCS 2007
- Country
- SISI China
- HSCS United States
- Employees
- SISI N/A
- HSCS N/A
- Industry
- SISI Medicinal Chemicals and Botanical Products
- HSCS Medical Specialities
- Sector
- SISI Health Care
- HSCS Health Care
- Exchange
- SISI Nasdaq
- HSCS Nasdaq
- Market Cap
- SISI 4.0M
- HSCS 3.7M
- IPO Year
- SISI 2016
- HSCS 2022
- Fundamental
- Price
- SISI $0.17
- HSCS $3.91
- Analyst Decision
- SISI
- HSCS Strong Buy
- Analyst Count
- SISI 0
- HSCS 2
- Target Price
- SISI N/A
- HSCS $13.00
- AVG Volume (30 Days)
- SISI 3.1M
- HSCS 162.8K
- Earning Date
- SISI 05-15-2025
- HSCS 09-11-2025
- Dividend Yield
- SISI N/A
- HSCS N/A
- EPS Growth
- SISI N/A
- HSCS N/A
- EPS
- SISI N/A
- HSCS N/A
- Revenue
- SISI $9,601,324.00
- HSCS N/A
- Revenue This Year
- SISI N/A
- HSCS N/A
- Revenue Next Year
- SISI N/A
- HSCS N/A
- P/E Ratio
- SISI N/A
- HSCS N/A
- Revenue Growth
- SISI 1133.26
- HSCS 261.17
- 52 Week Low
- SISI $0.15
- HSCS $2.36
- 52 Week High
- SISI $27.60
- HSCS $6.47
- Technical
- Relative Strength Index (RSI)
- SISI 29.18
- HSCS 49.18
- Support Level
- SISI $0.16
- HSCS $3.59
- Resistance Level
- SISI $0.18
- HSCS $4.27
- Average True Range (ATR)
- SISI 0.02
- HSCS 0.61
- MACD
- SISI 0.01
- HSCS -0.03
- Stochastic Oscillator
- SISI 19.22
- HSCS 11.72
About SISI Shineco Inc.
Shineco Inc aims to care for a healthy life and improve the quality of life by providing safe, efficient, and high-quality health products and services to society. The company has researched and developed various vitro diagnostic reagents and related medical devices to date, and it also produces and sells healthy and nutritious food.
About HSCS Heart Test Laboratories Inc.
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.